While most studies show a higher body mass in Western women to be positively associated with an increased breast cancer risk in postmenopausal women, they show a negative association in the case of premenopausal women. A review of case-control and cohort studies suggest that such protection applies mainly to obesity in teenage girls, whereas obesity appearing after the teenage years is more likely to be associated with a higher risk of postmenopausal breast cancer. The mechanisms are uncertain. There is evidence that obesity and the components of the Western diet can independently provoke hyperinsulinaemic insulin resistance at puberty, and in adolescent girls this has been related to evidence of abnormal ovarian steroidogenesis and anovulation. This may decrease promotion of mammary carcinogenesis. If however, obesity continues after the teenage years, the higher concentration of insulinlike growth factor 1 (IGF1) associated with hyperinsulinaemia can interact with oestrogen receptors in mammary epithelium to lead to increased proliferative activity.
Introduction
Studies on identical twins show that a tendency to obesity may be determined genetically. Its mechanism may involve genetic control of appetite drive or of energy expenditure. 1 However, most of the overweight which characterizes Western populations is determined by social and cultural factors and is subject to control. Considerable evidence shows that in women living in industrialised Western countries, the risk of pre-and postmenopausal breast cancer differs in its association with body mass. 2 The presence of a higher body mass is associated with an increased risk of postmenopausal breast cancer, but a modestly reduced risk of premenopausal breast cancer. However, in Asian countries with a relatively low incidence of breast cancer, a higher body mass is associated with an increased risk of both pre-and postmenopausal breast cancer. 3 Studies on the timing of weight gain are more likely to clarify the effect of obesity on breast cancer promotion than do measurements of body mass. 4 ,5 A review of case-control and cohort studies shows that obesity manifesting in the teenage years (`19 y) is associated with a reduced risk of breast cancer before the menopause, but less certainly after the menopause.
6 ± 11 However, if obesity appears after the teenage years, the risk of postmenopausal breast cancer is increased. 12 ± 16 The strongest evidence of this is provided by the USA Nurses Health Study involving more than 95 000 women aged 30 ± 55 y, followed for 16 y. 17 Overweight before the age of 18 y was associated with a reduced breast cancer risk before, and less so after, the menopause; overweight after 18 y was related to a higher risk of postmenopausal, although not of premenopausal, breast cancer.
A protective effect of adolescent obesity against premenopausal breast cancer risk has been attributed to an effect on ovarian hormone concentrations. Obesity in premenopausal women is frequently associated with a reduced serum level of oestradiol 18 and progesterone, 19 and anovulation has been suggested to explain the reduced risk of breast cancer. However, we need to examine the tendency for overweight in adolescent girls to persist in later life.
The widely quoted`breast-tissue age' model for human mammary carcinogenesis 20 postulates that international differences in breast cancer rates mainly re¯ect different timing of major hormonalmetabolic events, such as puberty, pregnancy and menopause. In this context, the presence of obesity at puberty is critical, because it is often related to the manifestation of insulin resistance. 21, 22 This review examines evidence that rich nutrition in childhood together with inadequate physical exercise are linked to (a) earlier onset of menarche, (b) earlier triggering of insulin resistance, (c) adolescent obesity and (d) increased tendency to obesity throughout adult life. The resulting increase in the risk of postmenopausal breast cancer will probably more than compensate for any protection from premenopausal breast cancer which may be conferred by teenage obesity.
Teenage obesity and mammary carcinogenesis
Both menarche before the age of 12 y and also a delayed ®rst full-term pregnancy are markers of increased breast cancer risk. Taken together, the observations suggest that a longer interval between the two events is important in the promotion of mammary carcinogenesis. 23 In addition, biological evidence suggests that the rapidly proliferating terminal end buds in developing mammary tissue are highly vulnerable to mutation in the experimental mammary cancer model. 24 Epidemiological observations con®rm this window of increased susceptibility. First, the risk of subsequent breast cancer among atomic bomb survivors was reported to be highest in women who were younger than 20 y at the time of exposure. 25 Second, the risk of subsequent breast cancer after repeated chest x-ray examinations for tuberculosis was reported to be highest among girls who were monitored between the ages of 10 ± 14 y. 26 Finally, it is reported that breast cancer risk among Japanese immigrants to the USA does not rise in the ®rst generation of women if they migrate after adolescence, 27 although in subsequent generations the risk gradually rises to approximate that of Caucasian-American women.
The epidemiological evidence reviewed in the Introduction suggests that teenage obesity may protect Western women against the appearance of breast cancer before the menopause. The protective effect has been attributed to the in¯uence of obesity by increasing anovulatory cycles, but the mechanism is uncertain. The concomitants of insulin resistance may be involved. 28 Obese adolescent girls show evidence of hyperinsulinaemia 22 and also a higher androgena oestrogen ratio in the circulation. 29 Higher concentrations of insulin can impair oocyte maturation in the ovary 30 and the resulting hormonal dysfunction has been postulated to reduce breast cancer risk. 28 Higher basal insulin concentrations are associated with obesity not only in adolescent girls, 22 but also in preadolescent girls, 31 the insulin concentration being correlated with magnetic resonance imaging (MRI) of visceral fat deposits. An increase in abdominal fat is common in girls at the time of puberty and is thought to be related to increasing levels of androgen and insulin. 21 Differences in the distribution of adipocyte receptors may then lead to a more truncal or visceral distribution of fat. 32 It is also reported that circulating concentrations of insulin-like growth factor 1 (IGF1) are signi®cantly higher in obese adolescent and preadolescent girls. 33, 34 The prevalence of insulin resistance varies between populations and there is strong evidence that in individuals with a genetic susceptibility its manifestation is favoured by the presence of obesity. 35 It is believed to result from an effect on skeletal muscle by a large release of non-esteri®ed fatty acids from adipose tissue.
1 In Western industrialised countries, it is estimated to affect as many as 25% of the normal population and is associated with hyperinsulinaemia. 35 
Nutrition, obesity and insulin resistance
What is the evidence that rich nutrition in childhood is linked to earlier onset of menarche, earlier triggering of insulin resistance, adolescent obesity and increased tendency to obesity throughout adult life? Early onset of menarche, associated with rich nutrition, is likely to be triggered by a threshold weight-for-height index 36 and a critical level of body fat. 37 Although a prospective study in Europe has reported a higher energyadjusted fat intake between the ages of 8 ± 15 y, to be associated with earlier menarche, 38 most evidence suggests that the effect of diet is to promote accumulation of adipose tissue, rather than through the intake of speci®c macronutrients. 39, 40 It is widely con®rmed that the risk of both pre-and postmenopausal breast cancer is increased in association with earlier onset of menarche (before the age of 12 y). Extreme leanness together with strenuous physical exercise are associated with delayed onset of menarche in ballet dancers and gymnasts, and a decreased breast cancer rate has been shown in athletes. 41 Nevertheless, no association has been shown between body mass in childhood (9 ± 14 y) and subsequent breast cancer risk. 7, 8, 10, 42 Although menarche is likely to be triggered by a threshold level of adiposity, the mechanism is uncertain. It has recently been suggested that a critical blood leptin concentration may trigger menarche through a hypothalamic mechanism. 43 Serum leptin concentrations, body-fat percentage and timing of menarche were recorded in 343 pubertal females in a four year study extending over the menarche. Serum leptin concentrations were strongly related to total body fat, and a rising leptin concentration was associated with a lowered age at menarche. However, a causative relationship is unclear.
Both insulin and IGF1 are likely to have a role in synchronising early sexual maturation with early linear growth. 44 Switching on of gonadotrophinTeenage obesity and breast cancer risk BA Stoll et al releasing hormone is associated with increased growth hormone secretion and also with evidence of hyperinsulinaemic insulin resistance. 45 Thus, earlier onset of puberty involves not only an earlier menarche, but also an earlier growth spurt. While catch-up may occur in adolescence, a subset of girls may proceed to greater adult height and there is considerable evidence from case-control and prospective studies, that taller women have an increased breast cancer risk. 46 Not only tallness, but also earlier completion of bone growth, is associated with a higher breast cancer risk. Comparison of 747 premenopausal breast cancer cases with controls showed a 30% reduction in breast cancer risk for women who reached their maximum height at 18 y compared to those who reached it at 13 y. 47 Girls who are fat in childhood usually attain menarche at a younger age 37, 48, 49 and girls who had an earlier menarche tend to greater obesity as young adults. 50, 51 A Dutch study has reported that in girls with an early onset of menarche, a higher body mass persisted until the age of 27 y. 52 The association has been reported to persist even into postmenopausal age both in Caucasian-Americans 50 and in African-American women. 53 Teenage obesity in Western girls is associated with an increased prevalence of menstrual irregularity, both long and short cycles, and a tendency to anovulation. 54 Teenage obesity is also associated with an increased likelihood of irregular menstrual cycles continuing into adult life. 55, 56 It is reported that in Western women regular ovulatory cycle are established relatively late and that about 50% of cycles in teenagers are anovulatory, the proportion only falling to 15 ± 20% after the age of 20 y. 54 Obesity in teenagers often continues into adult life 57 and about one third of obese adult women report obesity in adolescence. 21 In contrast, most Asian populations have a lower prevalence of obesity at all ages and do not show a reduced risk of premenopausal breast cancer to be associated with a higher body mass.
3 Obesity appearing after the teenage years is associated with increased risk of postmenopausal breast cancer in all populations and the overall incidence is about ®ve times greater in Western, than in Asian, populations.
Adolescent adiposity in girls is of two types 58 and even at the time of early puberty in girls, fat distribution can be distinguished as either predominantly gluteal (gynoid) or predominantly abdominal (android). Girls with the highest measures of abdominal fat show the greatest degree of obesity. While there is no evidence that body mass or body-fat distribution can trigger puberty in healthy girls, early sexual maturation is reported to be associated with increased deposits of abdominal fat. 58, 59 Western children, at the time of puberty, frequently show evidence of insulin resistance, which is compensated for by hyperinsulinaemia, and this is increased in the presence of obesity, particularly abdominal obesity. 60 Although they occur at the same time, early menarche and pubertal hyperinsulinaemia may exert opposing effects on ovarian steroid concentrations in teenagers. Onset of menarche before the age of 12 y is reported to be associated with earlier establishment of regular ovulatory cycles and an increased serum oestradiol level, which may still persist in women aged 20 ± 30 y, 61, 62 although another study has failed to con®rm the latter observation. 19 As noted in the previous section, pubertal hyperinsulinaemia is associated with a higher androgenaoestrogen ratio in the circulation and an increased tendency to anovulatory cycles.
There is no evidence that higher energy intake during adolescence may in¯uence subsequent breast cancer risk. A recent large case-control study of dietary fat intake in adolescence by women with premenopausal breast cancer showed no association, 63 and previous studies showed a similar result.
7,8,64
Although it is widely believed that the percentage of energy from body fat is an important determinant of obesity, there is no conclusive evidence that it is any more important than other macronutrients. 65, 66 Both obesity and insulin resistance are likely to be genetically determined, but there is so far no evidence of a genetic link between them. 67 The manifestation of insulin resistance in individuals who are genetically susceptible is in¯uenced by obesity, but also independently by the fatty acid pro®le of the Western diet. 68 Considerable research in rats and in humans has shown that the incorporation of more unsaturated fatty acids into the phospholipids of muscle cell membranes is associated with improved insulin actin, while a higher proportion of saturated fats is linked to insulin resistance. There is also evidence that a high ratio of n-6 to n-3 polyunsaturated fatty acids may favour insulin resistance. 68 Studies on obese children, around the age of puberty, have shown that insulin concentrations correlated positively with plasma lipid concentrations of n-6 polyunsaturated fatty acids, 69 but negatively with plasma lipid levels of n-3 polyunsaturated fatty acids. 70 It has been suggested that in some cases, the early manifestation of insulin resistance may be favoured by poor nutrition in fetal life (re¯ected by a low birthweight) interacting with abundant nutrition in later life. A series of studies has related low birthweight to evidence of impaired glucose tolerance and hyperinsulinaemia in children, 71 young adults 72 and older adults. 73 This may account for a report of reduced breast cancer risk in a group of mainly premenopausal women with a history of a birthweight`4000 g. 74 
Adult obesity increases mammary carcinogenesis
The mechanism by which weight gain after the teenage years increases breast cancer risk in Western Teenage obesity and breast cancer risk BA Stoll et al women is unclear, but considerable evidence con®rms that insulin resistance and hyperinsulinaemia increase with advancing age. Case-control studies have shown hyperinsulinaemia to be a marker of increased breast cancer risk both in pre-and postmenopausal women, independently of obesity. 75 ± 79 Hyperinsulinaemia is associated with increased levels of IGF1 and experimental evidence suggests that the type 1 IGF receptor plays an important role in breast cancer development. 80 The IGF1 receptor is expressed in human breast cancer specimens and in cell lines derived from them. Its concentration is higher in cancer cells than in normal breast tissue or benign tumours, and the IGF1 receptor interacts with the oestrogen receptor in stimulating proliferative activity both in cancer cells 81 and in explants of normal mammary epithelium. 82 IGF bioactivity in mammary tissue is in¯uenced by autocrine and paracrine secretion of IGF1 and IGF11, by circulating IGF1 levels and by the levels of IGFbinding proteins (IGFBPs) and IGFBP proteases.
83
IGF1 circulates as a complex, bound to IGFBPs, of which six appear to have a major role in maintaining the pool of bound IGF1 which responds to metabolic demands. 30 Proteolysis of IGFBP3 is regulated by insulin concentrations and is increased in the presence of insulin resistance suggesting a probable long-term regulating effect. On the other hand, IGFBP1 appears to regulate IGF availability, in response to acute changes in insulin concentrations. 30 Case-control studies have reported that mainly in premenopausal women the relationship between the circulating concentration of IGF1 and the bioactive concentration of IGFBP3 may be a marker of breast cancer risk. 79,84 ± 88 One study has failed to con®rm this ®nding. 89 Recent research shows that IGFBP3 acts not only by preventing IGF1 from binding to its receptor, but also has independent effects including the ability to induce programmed cell death (apoptosis) in human breast cancer cell lines. 90 A similar effect has been shown on human prostate cancer cell lines. 91 In the case of postmenopausal women, higher circulating oestrogen concentrations may also have a major role in the increased breast cancer risk associated with obesity. Several studies, including a large prospective study, 92 have shown a positive association between endogenous oestrogen concentrations and breast cancer risk. Obesity increases bioavailable oestrogen concentrations, partly as a result of increased conversion of adrenal androstenedione to oestrogen in fat, and partly as a result of decreased levels of sex hormone-binding globulin. 93 
Conclusion
Case control and cohort studies suggest that in industrialised Western populations, obesity in teenagers is associated with a modestly reduced risk of premenopausal breast cancer, while obesity appearing after the teenage years, is more likely to be associated with a higher risk of postmenopausal breast cancer. This review postulates that in Western girls, obesity and the fatty acid pro®le of the diet may independently provoke the onset of hyperinsulinaemic insulin resistance at puberty. Higher levels of insulin may impair ovarian steroidogenesis in teenage girls and thus decrease promotion of mammary carcinogenesis. After the teenage years, the higher levels of IGF1 associated with hyperinsulinaemia in obese women may interact with oestrogen receptors in mammary epithelium, leading to increased proliferative activity.
The overall incidence of breast cancer in Western industrialised populations is ®ve times greater than in Asian populations, which do not show a protective effect for teenage obesity. It is postulated that possible protection derived from teenage obesity in Western girls is temporary and small, compared to the risk of increased promotion of carcinogenesis when obesity continue after the teenage years. Teenage obesity may merely postpone breast cancer risk to an older age. Moreover, any perceived advantage from postponing breast cancer risk must be weighed against the increased risk of coronary heart disease (CHD) and atherosclerosis in later life, which is likely for obese adolescents aged between 13 ± 18 y. 94 Mechanisms may be clari®ed and the hypothesis tested following recent reports from case control studies that mainly in premenopausal women, the relationship between the circulating concentration of IGF1 and the bioactive concentration of IGFBP3 may be a marker of breast cancer risk. The important question is whether deliberate weight loss can reverse the effects of weight gain. 
